Review article: The natural history of paediatric-onset ulcerative colitis in population-based studies

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 3, 2016, Pages 346-355

  Fumery, M ^a   Duricova, D ^b,c   Gower Rousseau, C ^c,d,e   Annese, V ^c,f   Peyrin Biroulet, L ^g   Lakatos, P L ^c,h  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b CHARLES UNIVERSITY   (Czech Republic)

^c European Crohn's and Colitis Organization (ECCO)   (Austria)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIV LILLE   (France)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITÉ DE LORRAINE   (France)

^h SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; TUMOR NECROSIS FACTOR INHIBITOR;

ADOLESCENT; CHILD; COLON RESECTION; DELAYED PUBERTY; DISEASE COURSE; FOLLOW UP; GROWTH RETARDATION; HOSPITALIZATION; HUMAN; MORTALITY; ONSET AGE; PANCOLITIS; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM CARCINOMA; RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; DISEASE MANAGEMENT; PATHOPHYSIOLOGY;

ADRENAL CORTEX HORMONES; COLECTOMY; COLITIS, ULCERATIVE; DISEASE MANAGEMENT; DISEASE PROGRESSION; HUMANS;

EID: 84955340696     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13478     Document Type: Review

References (35)

1. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM,. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-39.
2. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A,. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94.
3. Levine A, Griffiths A, Markowitz J, et al,. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-21.
4. Silverberg MS, Satsangi J, Ahmad T, et al,. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5A-36A.
5. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al,. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 2009; 104: 2080-8.
6. Lovasz BD, Lakatos L, Horvath A, et al,. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis 2014; 46: 405-11.
7. Størdal K, Jahnsen J, Bentsen BS, Moum B,. Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up study. Digestion 2004; 70: 226-30.
8. Malaty HM, Abraham BP, Mehta S, Garnett EA, Ferry GD,. The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study. Clin Exp Gastroenterol 2013; 6: 77-83.
9. Urlep D, Trop TK, Blagus R, Orel R,. Incidence and phenotypic characteristics of pediatric IBD in northeastern Slovenia, 2002-2010. J Pediatr Gastroenterol Nutr 2014; 58: 325-32.
10. Jakobsen C, Bartek J Jr, Wewer V, et al,. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease-a population-based study. Aliment Pharmacol Ther 2011; 34: 1217-24.
11. Sjöberg D, Holmström T, Larsson M, et al,. Incidence and clinical course of Crohn's disease during the first year-results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis 2014; 8: 215-22.
12. Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, et al,. Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 2013; 19: 1218-23.
13. Turunen P, Ashorn M, Auvinen A, Iltanen S, Huhtala H, Kolho KL,. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009; 15: 56-62.
14. Jakobsen, et al,. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm Bowel Dis 2011; 17: 2541-50.
15. Hildebrand H, Karlberg J, Kristiansson B,. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994; 18: 165-73.
16. Schmidt S, Mellström D, Norjavaara E, Sundh SV, Saalman R,. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden. Inflamm Bowel Dis 2009; 15: 1844-50.
17. Tung J, Loftus EV Jr, Freese DK, et al,. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006; 12: 1093-100.
18. Jakobsen C, Munkholm P, Paerregaard A, Wewer V., Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators-a population-based study. Inflamm Bowel Dis 2011; 17: 1731-40.
19. Benchimol EI, Guttmann A, To T, Rabeneck L, Griffiths AM,. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis 2011; 17: 2153-61.
20. Benchimol EI, To T, Griffiths AM, Rabeneck L, Guttmann A,. Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. J Pediatr 2011; 158: 960-7.
21. Benchimol EI, Mack DR, Nguyen GC, et al,. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 2014; 147: 803-13.
22. Debruyn JC, Soon IS, Hubbard J, Wrobel I, Panaccione R, Kaplan GG,. Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009. Inflamm Bowel Dis 2013; 19: 2423-32.
23. Langholz E, Munkholm P, Krasilnikoff PA, Binder V,. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997; 32: 139-47.
24. Penninck E, Fumery M, Armengol-Debeir L, et al,. Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis. 2015; [Epub ahead of print].
25. Peneau A, Savoye G, Turck D, et al,. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol 2013; 108: 1647-53.
26. Jess T, Horevath-Puho E, Fallingborg J, et al,. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population based cohort. Am J Gastroenterol 2013; 108: 1869-76.
27. Jess T, Simonsen J, Jorgensen KT, et al,. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012; 143: 375-81.
28. Jess T, Frisch M, Simonsen J, et al,. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013; 11: 43-8.
29. Card T, Hubbard R, Logan R,. Mortality in inflammatory bowel disease: a population-based study. Gastroenterology 2003; 125: 1583-159.
30. Van Limbergen J, Russell RK, Drummond HE, et al,. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135: 1114-22.
31. Ruel J, Ruane D, Mehandru, Gower-Rousseau C, Colombel JF., IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014; 11: 88-98.
32. Kelsen J, Baldassano R,. Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis 2008; 14 (Suppl. 2): S9-11.
33. Reich KM, Chang HJ, Rezaie A,. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther 2014; 40: 629-38.
34. Gornet JM, Couve S, Hassani Z, et al,. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther 2003; 18: 175-81.
35. Jakobsen C, Paerregaard A, Munkholm P, et al,. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis-a population-based study from the Danish Crohn Colitis Database. Eur J Gastroenterol Hepatol 2009; 21: 1291-301.